Interview with
Accelr8 Technology Corporation (AXK - AMEX)
Crystal Research Associates provides independent equity research coverage of Accelr8 Technology Corporation (AXK-AMEX), including a company snapshot, executive informational overview (EIO), and quarterly updates.
Accelr8 Technology Corporation is headquartered in Denver, Colorado. The Company is developing technology to correctly identify bacterial species, compute bacterial counts in the original specimen, and accurately measure antibiotic resistance in critically ill patients within a fraction of the time required for current standard culturing methods.
Please visit the Research Coverage link below for greater details on Accelr8 Technology, including the base reports and quarterly updates.